Documented symptomatic hypoglycemia and/or self-reported hypoglycemia
| Population . | Control . | Intervention . | P . |
|---|---|---|---|
| Entire sample | |||
| Hypo <54 | 9% (4/44) | 11% (6/52) | 0.75 |
| Number of events, mean (SD) | 0.2 (0.82) | 0.38 (1.29) | 0.43 |
| Hypo <70 | 36% (16/44) | 28% (15/52) | 0.51 |
| Number of events, mean (SD) | 0.86 (1.97) | 0.69 (1.5) | 0.63 |
| Inclusion criteria HbA1c 7.5≤ and ≤10% (58≤ and ≤86 mmol/mol) | |||
| Hypo <54 | 8% (3/37) | 13% (6/43) | 0.40 |
| Hypo <70 | 37% (14/37) | 32% (14/43) | 0.62 |
| HbA1c at baseline of 7.5–8.5% (58–69 mmol/mol) | |||
| Hypo <54 | 5% (1/18) | 9% (2/22) | 0.67 |
| Hypo <70 | 38% (7/18) | 36% (8/22) | 0.87 |
| HbA1c at baseline of 8.5–10% (69–86 mmol/mol) | |||
| Hypo <54 | 11% (2/8) | 18% (4/22) | 0.52 |
| Hypo < 70 | 38% (7/18) | 27% (6/22) | 0.44 |
| Population . | Control . | Intervention . | P . |
|---|---|---|---|
| Entire sample | |||
| Hypo <54 | 9% (4/44) | 11% (6/52) | 0.75 |
| Number of events, mean (SD) | 0.2 (0.82) | 0.38 (1.29) | 0.43 |
| Hypo <70 | 36% (16/44) | 28% (15/52) | 0.51 |
| Number of events, mean (SD) | 0.86 (1.97) | 0.69 (1.5) | 0.63 |
| Inclusion criteria HbA1c 7.5≤ and ≤10% (58≤ and ≤86 mmol/mol) | |||
| Hypo <54 | 8% (3/37) | 13% (6/43) | 0.40 |
| Hypo <70 | 37% (14/37) | 32% (14/43) | 0.62 |
| HbA1c at baseline of 7.5–8.5% (58–69 mmol/mol) | |||
| Hypo <54 | 5% (1/18) | 9% (2/22) | 0.67 |
| Hypo <70 | 38% (7/18) | 36% (8/22) | 0.87 |
| HbA1c at baseline of 8.5–10% (69–86 mmol/mol) | |||
| Hypo <54 | 11% (2/8) | 18% (4/22) | 0.52 |
| Hypo < 70 | 38% (7/18) | 27% (6/22) | 0.44 |
Data are % of patients (number of patients with at least one hypoglycemic event/total evaluated patients) unless otherwise indicated. P values were calculated using the Wald or Wilson test for proportions. Hypo, hypoglycemia (mg/dL).